Browse By

Category Archives: Biotech&Pharma

[Biotech&Pharma] CytoDyn’s First mTNBC Patient in Phase 1b/2 is in Remission and Oncologist Ordered Termination of Treatment with Carboplatin (chemotherapy drug) and Remains on Leronlimab Only as Monotherapy; Patient’s Testimony about Her Condition After Nearly 6 Months of Leronlimab Treatment is Very Strong

VANCOUVER, Washington, March 12, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company … Source Benzinga Disclaimer: All posts made on this website are provided for information purposes only. None of the information here is intended as investment